Haleon plc (HLN)

NYSE: HLN · IEX Real-Time Price · USD
6.36
+0.01 (0.16%)
Aug 16, 2022 3:59 PM EDT - Market closed
0.16%
Market Cap 29.37B
Revenue (ttm) 12.73B
Net Income (ttm) 1.85B
Shares Out 4.62B
EPS (ttm) 0.37
PE Ratio 17.19
Forward PE 15.17
Dividend n/a
Ex-Dividend Date n/a
Volume 8,732,419
Open 6.39
Previous Close 6.35
Day's Range 6.24 - 6.52
52-Week Range 6.04 - 7.56
Beta n/a
Analysts Buy
Price Target 8.37 (+31.6%)
Earnings Date n/a

About HLN

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed ... [Read more...]

Industry Drug Manufacturers-Specialty & Generic
Founded 2022
Employees 22,800
Stock Exchange NYSE
Ticker Symbol HLN
Full Company Profile

Financial Performance

In 2021, Haleon's revenue was 9.55 billion, a decrease of -3.51% compared to the previous year's 9.89 billion. Earnings were 1.39 billion, an increase of 21.40%.

Financial numbers in GBP Financial Statements

Analyst Forecast

According to 19 analysts, the average rating for HLN stock is "Buy." The 12-month stock price forecast is 8.37, which is an increase of 31.60% from the latest price.

Price Target
$8.37
(31.60% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Potential Lawsuits Causing Zantac Manufacturers Heartburn

Concerns over potential liability for a medication purported to cause cancer sliced billions off the value of several manufacturers of the drug in the past week. But were the cuts too deep?

Other symbols: GSKJNJPFESNY

PFE, GSK & Other Pharma Stocks Hit by Zantac Litigation

Big pharma stocks, such as Glaxo (GSK), Sanofi (SNY), Pfizer (PFE) and Consumer stock Haleon (HLN), decline due to the litigation surrounding the heartburn drug Zantac (ranitidine).

Other symbols: GSKPFESNY

Pharma companies see sales slump amid ongoing Zantac litigation

Yahoo Finance health care reporter Anjalee Khemlani looks at which pharmaceutical stocks are being affected by litigation surrounding alleged carcinogenic materials in Zantac derivatives.

Other symbols: GSKSNY

Drugmaker stocks slammed over Zantac lawsuit concerns

Thousands of lawsuits have been filed against companies including Sanofi, GlaxoSmithKline, Haleon and Pfizer accusing them of failing to properly warn users of the recalled heartburn drugs' health risks.

Other symbols: GSKPFESNY

Drugmakers' shares tumble on growing investor fears over Zantac litigation

CNBC's Julianna Tatelbaum discusses U.S. litigation focused on heartburn drug Zantac.

Other symbols: GSKSNY

GSK, Sanofi and Haleon shares stabilise after Zantac litigation slump

Shares in GSK, Sanofi

Other symbols: GSKSNY

Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms

Pharmaceutical stocks GSK, Sanofi and Haleon extended deep losses Thursday amid looming litigation around recalled heartburn drug Zantac. The post Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Z...

Other symbols: GSKSNY

Drug stocks under pressure over Zantac litigation concerns

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss alleged concerns that Sanofi and GSK's antacid drug Zantac causes cancer.

Other symbols: GSKSNY

Haleon not a party to U.S. litigation focused on Zantac - spokesperson

Haleon - GSK's recently spun off consumer health unit - is not a party to the U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday.

GSK, Sanofi and Haleon slump on worries over Zantac litigation

European-listed shares of drugmakers Haleon HLN, -11.81% , GSK GSK, -8.48% and Sanofi SAN, -8.81% plunged on Thursday on worries over the Zantac heartburn medication litigation. The first trial is set t...

Other symbols: GSKSNY

Haleon: The 'Good Health Lion' Now Stalks the Drug Store Aisle

Haleon PLC ( HLN , Financial) is the world's largest consumer health care company, which was recently spun off of GSK PLC ( GSK , Financial). The company's name was formed from merging the words "hale,"...

GSK or Haleon: Which Is the Real Beneficiary of This Spinoff?

GSK PLC ( GSK , Financial) completed the long-awaited spinoff of its consumer health care business Haleon ( HLN , Financial) on July 18. Shareholders received one Haleon share for each GSK share owned.

Other symbols: GSK

Could GSK's Haleon Spinoff Backfire?

GSK PLC ( GSK , Financial) completed the long-awaited spinoff of its consumer health care business Haleon ( HLN , Financial) on July 18. Shareholders received one Haleon share for each GSK share owned.

Other symbols: GSK